BILL ANALYSIS
HR8306
NEUTRALSCALE Act
HR8306 (SCALE Act) carries an AI-assessed market impact score of 4/10 with a neutral outlook for investors. This legislation directly affects NVIDIA ($NVDA), Advanced Micro Devices ($AMD), Intel ($INTC) and $SMCI. The primary sectors impacted are Technology and Defense. View the full bill text on Congress.gov.
4/10
Impact Score
neutral
Market Sentiment
4
Affected Stocks
2
Sectors Impacted
Key Takeaways for Investors
SCALE Act creates a permanent annual process for AI chip export thresholds — no funding attached.
Early legislative stage: introduced 4/15/26, referred to two committees, no Senate companion. Low probability of passage in this Congress.
For AI chip exporters, the bill turns ad-hoc export controls into a predictable annual review — reducing surprise bans but formalizing long-term restrictions.
No explicit dollar amounts or new programs; purely a regulatory process mandate.
How HR8306 Affects the Market
The immediate market implications are minimal given the bill's early stage. Over a 12-24 month horizon, if the bill advances, semiconductor companies with China/restricted-market revenue ($NVDA, $AMD, $SMCI) would face formalized annual revenue ceilings for that segment. Intel's foundry business could see incremental demand from customers prioritizing U.S.-based fabrication. The bill does not alter current trade policy — it codifies an existing trend into statute. No real market data available to assess price reactions.
Bill Details
| Metric | Value |
|---|---|
| Bill Number | HR8306 |
| Impact Score | 4/10Certainty: Committee hearing · Financial Magnitude: No explicit funding identified · Strategic Weight: AI qualitative assessment: 4/10 · Market Penetration: 4 companies — broad impact across 2 sectors |
| Market Sentiment | neutral |
| Event Date | |
| Affected Sectors | Technology, Defense |
| Affected Stocks | NVIDIA ($NVDA), Advanced Micro Devices ($AMD), Intel ($INTC), $SMCI |
| Source | View on Congress.gov → |
Summary
The SCALE Act (HR8306) is an early-stage House bill introducing an annual, systematic process to recalibrate export controls on AI-capable chips to adversaries. It authorizes no funding. For semiconductor and AI infrastructure companies, it codifies existing restriction regimes into a predictable annual process — reducing ad-hoc export bans but capping upside from restricted markets. Market impact is neutral-to-modestly-bearish for companies with significant China revenue exposure ($NVDA, $AMD, $SMCI).